Solid Biosciences Inc (NASDAQ:SLDB) has a beta value of 2.40 and has seen 0.81 million shares traded in the recent trading session. The company, currently valued at $223.18M, closed the recent trade at $2.88 per share which meant it gained $0.33 on the day or 12.94% during that session. The SLDB stock price is -281.6% off its 52-week high price of $10.99 and 14.93% above the 52-week low of $2.45. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.16 million shares traded. The 3-month trading volume is 2.51 million shares.
The consensus among analysts is that Solid Biosciences Inc (SLDB) is Buy stock at the moment, with a recommendation rating of 1.08. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 6 have rated it as a Hold, with 6 advising it as a Buy. 0 have rated the stock as Underweight.
Solid Biosciences Inc (NASDAQ:SLDB) trade information
Over the past 30 days, the shares of Solid Biosciences Inc (NASDAQ:SLDB) have changed -38.72%. Short interest in the company has seen 8.62 million shares shorted with days to cover at 7.37.
Wall Street analysts have a consensus price target for the stock at $19, which means that the shares’ value could jump 84.84% from the levels at last check today.. The projected low price target is $12.0 while the price target rests at a high of $20.0. In that case, then, we find that the latest price level in today’s session is -594.44% off the targeted high while a plunge would see the stock gain -316.67% from the levels at last check today..
Solid Biosciences Inc (SLDB) estimates and forecasts
The company’s shares have lost -58.92% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 41.25% over the past 5 years. Earnings growth for 2025 is a modest 28.29% while over the next 5 years, the company’s earnings are expected to increase by 18.18%.
SLDB Dividends
Solid Biosciences Inc is expected to release its next earnings report on 2025-Mar-05 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Solid Biosciences Inc (NASDAQ:SLDB)’s Major holders
Insiders own 0.70% of the company shares, while shares held by institutions stand at 65.68% with a share float percentage of 66.14%. Investors are also buoyed by the number of investors in a company, with Solid Biosciences Inc having a total of 127.0 institutions that hold shares in the company. The top two institutional holders are PERCEPTIVE ADVISORS LLC with over 6.91 million shares worth more than $39.16 million. As of 2024-06-30, PERCEPTIVE ADVISORS LLC held 16.8725% of shares outstanding.
The other major institutional holder is RA CAPITAL MANAGEMENT, L.P., with the holding of over 4.33 million shares as of 2024-06-30. The firm’s total holdings are worth over $24.55 million and represent 10.579% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Select Portfolios-Biotechnology Portfolio and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . As of Feb 28, 2025 , the former fund manager holds about 4.53% shares in the company for having 3.51 shares of worth $10.02 million while later fund manager owns 854.68 shares of worth $2.44 million as of Dec 31, 2024 , which makes it owner of about 1.10% of company’s outstanding stock.
